Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial cell wall is a rigid structure surrounding the cell membrane of most bacteria, composed primarily of peptidoglycan, a complex polymer of sugars (N-acetylglucosamine and N-acetylmuramic acid) cross-linked by short peptides[1][2][3][4]. The wall provides mechanical strength, maintains cell shape, and prevents osmotic lysis. Its biosynthesis and remodeling depend on numerous enzymes, including transpeptidases (also known as penicillin-binding proteins), transglycosylases, autolysins, and muramidases[2][3][4]. These enzymes are essential for cell growth and division and are major targets for many classes of antibiotics, such as beta-lactams and glycopeptides[3][4][6]. Inhibition or degradation of the cell wall disrupts bacterial survival, making these enzymes critical therapeutic targets for treating bacterial infections. Modifications in cell wall structure or in these enzymes underlie important mechanisms of antibiotic resistance. Because mammalian cells lack peptidoglycan and these enzymes, drugs targeting them often have high therapeutic specificity and safety[2][4].
Inhibition of peptidoglycan cross-linking (beta-lactams inhibit penicillin-binding proteins, especially transpeptidases)[2][3][4][6] - Inhibition of cell wall subunit synthesis (fosfomycin, bacitracin) - Inhibition of glycan polymerization (glycopeptides block transglycosylation and transpeptidation steps) - Degradation of peptidoglycan (lysozyme, autolysins, muramidases)[2][3]
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptidoglycan cell wall synthesis enzyme.